- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07580248
Effects of Supplementation on Performance in Football Players (FOOTBALL-TCP)
Effects of Combined Taurine, Caffeine, and Phosphatidylserine Supplementation on Physical and Cognitive Performance in Professional Male Football Players
This study investigated the effects of short-term supplementation with taurine, caffeine, and phosphatidylserine on physical and cognitive performance in professional male football players. Eighty-one players were randomly assigned to one of three groups: placebo, taurine plus caffeine, or taurine plus caffeine combined with phosphatidylserine. Supplementation was administered for 10 days, with a final dose taken 60 minutes before a standardized 105-minute football training session.
Primary and secondary outcomes included sprint performance, reaction time, GPS-derived locomotor variables, and technical and tactical performance indicators. The aim of the study was to evaluate whether combined multi-ingredient supplementation could improve performance and attenuate fatigue-related declines under match-like conditions.
Przegląd badań
Status
Szczegółowy opis
This randomized, placebo-controlled, single-blind study evaluated the effects of combined supplementation with taurine, caffeine, and phosphatidylserine on physical and cognitive performance in professional male football players.
Eighty-one participants aged 19-32 years were randomly assigned to one of three groups: placebo (lactose), taurine plus caffeine (1500 mg taurine + 200 mg caffeine), or taurine plus caffeine plus phosphatidylserine (1500 mg taurine + 150 mg caffeine + 300 mg phosphatidylserine daily for 10 days). All participants completed a 10-day supplementation period, followed by a standardized 105-minute football training session.
Outcome measures included sprint performance (30 m sprint time), reaction time (visual and auditory), GPS-derived variables (total distance, sprint activity, speed, accelerations, and decelerations), and technical and tactical performance indicators assessed by coaching staff and video analysis.
The study was conducted under controlled environmental conditions and in accordance with standardized training procedures. Data were analyzed using analysis of variance (ANOVA) with post hoc testing. The aim was to determine whether multi-ingredient supplementation could enhance performance and reduce fatigue-related declines in a football-specific setting.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Łódżkie
-
Lodz, Łódżkie, Polska, 94-020
- ŁKS Łódź
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dorosły
Akceptuje zdrowych ochotników
Opis
Inclusion Criteria:
- Male professional football (soccer) players
- Age 19-32 years
- Currently participating in regular team training (4-5 sessions per week)
- Medically cleared for participation in high-intensity physical activity
- Provided written informed consent
Exclusion Criteria:
- Current injury or musculoskeletal condition affecting performance
- Chronic disease or medical condition
- Use of medications that may affect physical or cognitive performance
- Regular use of dietary supplements or caffeine prior to the study period
- Smoking or alcohol consumption
- Failure to comply with study procedures
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Podstawowa nauka
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Podwójnie
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Komparator placebo: Placebo
Participants received a placebo (lactose) daily for 10 days.
|
Placebo (lactose) administered daily for 10 days
|
|
Eksperymentalny: Taurine + Caffeine
Participants received taurine (1500 mg) and caffeine (200 mg) daily for 10 days.
|
Taurine 1500 mg and caffeine 200 mg administered daily for 10 days
|
|
Eksperymentalny: Taurine + Caffeine + PS
Participants received taurine (1500 mg), caffeine (150 mg), and phosphatidylserine (300 mg) daily for 10 days.
|
Taurine 1500 mg, caffeine 150 mg, and phosphatidylserine 300 mg administered daily for 10 days
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
30 m sprint time (seconds)
Ramy czasowe: Day 10 (final training session following supplementation)
|
Time to complete a 30 meter sprint under standardized conditions, expressed in seconds; calculated as the mean of valid trials.
|
Day 10 (final training session following supplementation)
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Reaction time (visual and auditory)
Ramy czasowe: Day 10 (post-supplementation)
|
Visual and auditory reaction time measured using standardized computerized reaction time tests (e.g., validated software-based assessment tools), expressed as mean response time in seconds across valid trials.
|
Day 10 (post-supplementation)
|
|
Total distance (meters)
Ramy czasowe: Day 10 (during standardized training session)
|
Total distance covered during the standardized training session, measured using GPS tracking devices (e.g., 10 Hz GPS units), expressed in meters.
|
Day 10 (during standardized training session)
|
|
Running speed (m/s)
Ramy czasowe: Day 10 (during standardized training session)
|
Mean running speed during the standardized training session, measured using GPS tracking devices (e.g., 10 Hz GPS units), expressed in meters per second.
|
Day 10 (during standardized training session)
|
|
Sprint count (number)
Ramy czasowe: Day 10 (during standardized training session)
|
Total number of sprint efforts recorded during the standardized training session using GPS tracking devices.
|
Day 10 (during standardized training session)
|
|
High-speed running distance (meters)
Ramy czasowe: Day 10 (during standardized training session)
|
Distance covered at high-speed running thresholds during the standardized training session, measured using GPS tracking and expressed in meters.
|
Day 10 (during standardized training session)
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Sprint time decline (%)
Ramy czasowe: Day 10 (during final training session; comparison between first and second halves)
|
Percentage decline in 30 m sprint time between the first and second halves of the standardized training session, measured using electronic timing gates and expressed as percentage change.
|
Day 10 (during final training session; comparison between first and second halves)
|
|
Running speed decline (%)
Ramy czasowe: Day 10 (during final training session; comparison between first and second halves)
|
Percentage decline in running speed between the first and second halves of the standardized training session, measured using GPS tracking devices and expressed as percentage change.
|
Day 10 (during final training session; comparison between first and second halves)
|
|
Passing accuracy (%)
Ramy czasowe: Day 10 (during standardized training session)
|
Percentage of successful passes during the standardized training session, assessed using video-based performance analysis and expressed as a percentage.
|
Day 10 (during standardized training session)
|
|
Dribbling success (%)
Ramy czasowe: Day 10 (during standardized training session)
|
Percentage of successful dribbling attempts during the standardized training session, assessed using video-based performance analysis and expressed as a percentage.
|
Day 10 (during standardized training session)
|
|
Ball recoveries (number)
Ramy czasowe: Day 10 (during standardized training session)
|
Total number of ball recoveries performed during the standardized training session, assessed using video-based performance analysis and expressed as a count.
|
Day 10 (during standardized training session)
|
|
Tactical performance score (units)
Ramy czasowe: Day 10 (during standardized training session)
|
Coach-rated tactical performance during the standardized training session, including positioning, decision-making, and support play, assessed using a standardized rating scale and expressed in standardized score units.
|
Day 10 (during standardized training session)
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Krzysztof Maciej MIZERA, PhD, 1. Vizja University in Warsaw, Faculty of Medical Sciences and Health Sciences, 01-143 Warsaw, Poland
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
- Związki siarki
- Organiczne chemikalia
- Związki heterocykliczne
- Związki heterocykliczne, 2-ring
- Związki heterocykliczne, sterowanie stopieniem
- Lipidy
- Węglowodory, acykliczne
- Węglowodory
- Alkaloidy
- Puryny
- Puryny
- Alkan
- Kwasy alkanesulfonowe
- Kwasy sulfonowe
- Kwasy siarkowe
- Lipidy błony
- Ksantiny
- Glicerofosfolipidy
- Kwasy fosfatydowe
- Glicerofosforany
- Fosfolipidy
- Kofeina
- Byczy
- Fosfatydyloseryny
Inne numery identyfikacyjne badania
- MIZERA-2025-FOOTBALL-RCT
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Wydajność poznawcza
-
Atılım UniversityJeszcze nie rekrutacjaReformer Pilates Ćwiczenie, Cognitive Performans
-
Pamukkale UniversityRejestracja na zaproszenieOcena poznawcza | Elektrowstrząsy (ECT) | Ocena Poznawcza Terapii Elektrowstrząsowej (ECCA) | Montreal Cognitive Assessment (MoCA) | Turecka adaptacjaTurcja (Türkiye)
Badania kliniczne na Placebo
-
SamA Pharmaceutical Co., LtdNieznanyOstre zapalenie oskrzeli | Ostra infekcja górnych dróg oddechowychRepublika Korei
-
National Institute on Drug Abuse (NIDA)ZakończonyUżywanie konopi indyjskichStany Zjednoczone
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyZakończonyMężczyźni z cukrzycą typu II (T2DM)Niemcy
-
AkesoJeszcze nie rekrutacjaAtopowe zapalenie skóryChiny
-
Heptares Therapeutics LimitedZakończonyFarmakokinetyka | Problemy z bezpieczeństwemZjednoczone Królestwo
-
CellmedisMedical Network Sp. z o.o.Jeszcze nie rekrutacja
-
Soroka University Medical CenterZakończony
-
Regado Biosciences, Inc.ZakończonyZdrowy ochotnikStany Zjednoczone
-
West Penn Allegheny Health SystemZakończonyAstma | Alergiczny nieżyt nosaStany Zjednoczone